Theralase Technologies Inc. V.TLT

RE:RE:RE:4 Canadian sites currently recruiting !

[Macer]

Eoganacht wrote: Macer, if a patient is cancer free a year after their initial treatment, would they be excluded because they did not receive the second treatment?

Macer wrote:

Thor6570 wrote: Intravesical Photodynamic Therapy (PDT) in BCG Refractory/Intolerant Non-Muscle Invasive Bladder Cancer (NMIBC) Patients - Full Text View - ClinicalTrials.gov

The site was last updated on May 19 2020.
Theralase will need to PR information about the trial restarting. Would love to say that this is happening soon as clinical activities and other research is moving forward. Unfortunately we know this companies track record with timelines.
I emailed RW last week with some questions around the trial being delayed south of the border because of the way those baffoons have dropped the ball on COVID containement. In the past he has provided me with responses. When he has not responded his silence has been very telling. He has yet to respond.

I would love to be wrong on this but I feel that we are in for a long hall here. I even have concerns about the patients that have already been enrolled and treated missing their window for second treatments and thus being excluded from the study due to lack of ability to follow the protocol.

Macer

Not likely. If they are cancer free at one year with just 1 treatment then everything is fine. However, if some have residual disease that progresses from 6mo-1yr without the second treatment, they may not be eligable for inclusion in the outcomes analysis. Good for the study but crappy for our timeline.
Macer